Unassociated Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) 
 
November 10, 2011
 
ALLIED HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
0-19266
25-1370721
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

1720 Sublette Avenue, St. Louis, Missouri
(Address of principal executive offices)
63110
(Zip Code)

Registrant’s telephone number, including area code 
(314) 771-2400 
  
Not applicable 
(Former name or former address, if changed since last report) 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

ITEM 5.07. Submission of Matters to a Vote of Security Holders.
 
The annual meeting of the stockholders of Allied Healthcare Products, Inc. (the “Company”) was held on November 10, 2011. Proxies were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934.  There was no solicitation in opposition to management’s nominees for Directors.  The voting results are noted below.
 
ELECTION OF DIRECTORS
 
All nominees for Directors were elected with the following votes cast:
 
    For     Withheld   Broker Non-Votes
               
Judith T. Graves
    6,844,873       11,252  
NA
Joseph E. Root
    6,845,523       10,602  
NA
William A. Peck
    6,840,808       15,317  
NA
Earl R. Refsland
    6,839,408       16,717  
NA
John D. Weil
    6,813,557       42,568  
NA
 
PROPOSAL A

Proposal A, concerning the ratification of the appointment of RubinBrown LLP as the Company's independent registered public accounting firm for fiscal 2012 was approved by the stockholders with the following votes cast:
 
For
 
Against
   
Abstain
 
Broker Non-Votes
7,877,838
    7,116       5,635  
NA

 
 

 
 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
ALLIED HEALTHCARE PRODUCTS, INC.
 
       
Date:  November 10, 2011   
By:
/s/ Daniel C. Dunn  
    Daniel C. Dunn  
   
Chief Financial Officer